Invesaro

Stocks TSNDF Financial statements

Financial statements

TerrAscend Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data TerrAscend Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2022FY2022FY2023FY2024FY2025
Revenue139201249251268261
Cost of revenue46.581.7146112132124
Gross profit85.7113102138136136
Research and development0.14
Selling, general and administrative60.875.1116115
Selling and marketing1.671.8610.39.66
General and administrative60.875.111683.590.686.2
Operating expenses65.189.643710896.994.3
Operating income20.622.9-33629.738.942
Interest expense1.9621.226.831.127.528.8
Other non-operating income-0.390.230.21-0.80.850.89
Pre-tax income-11744.5-310-4.244.244.98
Income tax10.828.9-10.823.425.129.5
Income from continuing operations-13912.6-304-36.4-28.5-29.4
Net income to minority interests3.024.568.827.564.9
Net income-1426.14-325-86.7-72.7-81.3
EBITDA24.428.4-32635.54447.4
EPS, basic-1.030.02-1.35-0.34-0.28-0.29
EPS, diluted-1.030.01-1.35-0.34-0.28-0.29
Shares, basic (weighted)150181244279292301
Shares, diluted (weighted)150209244279292301

Balance sheet

FY2020FY2022FY2022FY2023FY2024FY2025
Cash and equivalents79.626.222.226.437.4
Short-term investments3.61.911.730.36
Receivables12.522.41920.216.9
Inventory36.146.351.739.734.1
Other current assets5.035.514.95.128.56
Total current assets172122103177110
Property, plant and equipment112216196124130
Lease right-of-use assets43.429.543.428.826.7
Goodwill72.890.390.3107107110
Intangible assets168240216170167
Other non-current assets3.143.460.850.7213.5
Total assets582702667607557
Accounts payable27.944.349.940.339.8
Deferred revenue1.072.944.153.583.99
Short-term debt39126
Total current liabilities66.21382079179.9
Lease liabilities30.631.545.430.728.6
Other non-current liabilities13.115.82.120.090.09
Total liabilities353380426430458
Total debt200206205225
Paid-in capital535935945952960
Retained earnings-315-618-704-779-865
Treasury stock000
Other comprehensive income2.822.091.83.011.99
Minority interests3.85.372.37-1.76-0.141.54
Total equity-13.322932124117799
Total liabilities and equity582702667607557
Shares outstanding191260288293309

Cash flow statement

FY2020FY2022FY2022FY2023FY2024FY2025
Net income-1426.14-325-86.7-72.7-81.3
Depreciation and amortization3.895.539.665.765.075.42
Stock-based compensation10.514.912.27.719.715.01
Deferred income tax-12-1.25-35.3-10.31.37-0.53
Change in receivables-4.04-3.212.86-8.68-5.31.65
Change in inventory-8.09-18.50.68-4.251.175.95
Cash from operations-37-31.8-26.127.53821.5
Capital expenditures-43.8-39.8-39.6-4.87-6.87-8.61
Acquisitions-29.7-7.04-0.75-4.93-0.39
Cash from investing-45.9-132-27.6-16.2-12.2-14.6
Debt issued1960.7743.423.912978.9
Debt repaid-48.9-4.5-42.2-42.8-137-70.5
Stock issued0.1
Share buybacks-0.22-0.41
Cash from financing1331823.72-12.5-24.74.19
Net change in cash50.518-50-1.250.9911.1
Free cash flow-80.8-71.7-65.822.631.112.9
Interest paid1.9621.226.82323.827.9
Income taxes paid11.237.1-9.92-3.28-5.039.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.61 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin52.8%Gross profit / revenue.
Operating margin16.1%Operating income / revenue.
EBITDA margin18.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.5%Pre-tax income / revenue.
Net margin-14.0%Net income / revenue.
FCF margin7.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin9.8%Cash from operations / revenue.
Effective tax rate801.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)-6.7%Net income / average total assets.
Stock-based pay / revenue1.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.5%Capital expenditures / revenue.
D&A / revenue2.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-2.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y0.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y9.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y8.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y15.4%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y7.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y14.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-43.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-58.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-8.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-7.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y3.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y7.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y15.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.83xCurrent assets / current liabilities.
Quick ratio0.94x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.68x(Cash + short-term investments) / current liabilities.
Debt / assets37.9%Total debt / total assets.
Liabilities / assets84.8%Total liabilities / total assets.
Net debt$167.6MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.48xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage1.42xOperating income / interest expense.
Working capital$51.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets52.2%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.48xRevenue / average total assets.
Fixed asset turnover2.13xRevenue / average property, plant and equipment.
Inventory turnover3.18xCost of revenue / average inventory.
Days inventory115 days365 x average inventory / cost of revenue.
Receivables turnover16.2xRevenue / average receivables.
Days sales outstanding23 days365 x average receivables / revenue.
Days payables118 days365 x average accounts payable / cost of revenue.
Cash conversion cycle20 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow25.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.12Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.85Revenue / diluted weighted shares.
FCF per share$0.06Free cash flow / diluted weighted shares.
Operating cash flow per share$0.08Cash from operations / diluted weighted shares.
Cash per share$0.14(Cash + short-term investments) / shares outstanding.
Buybacks / FCF2.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$188.6MShare price x shares outstanding.
Enterprise value$356.2MMarket cap + total debt - cash - short-term investments.
P/S0.71xMarket cap / revenue.
P/FCF9.77xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF7.32xMarket cap / cash from operations, when positive.
EV/Sales1.35xEnterprise value / revenue.
EV/EBIT8.39xEnterprise value / operating income, when both are positive.
EV/EBITDA7.40xEnterprise value / EBITDA, when both are positive.
EV/FCF18.4xEnterprise value / free cash flow, when both are positive.
FCF yield10.2%Free cash flow / market cap.
Earnings yield-19.6%Net income / market cap (the inverse of P/E).
Shareholder yield0.2%(Dividends paid + share buybacks) / market cap.
What was TerrAscend Corp.'s revenue in fiscal 2025?

TerrAscend Corp. reported revenue of $260.6M for fiscal 2025, 2.8% lower than the year before.

Was TerrAscend Corp. profitable in fiscal 2025?

No. It reported a net loss of $81.3M.

How much free cash flow did TerrAscend Corp. generate in fiscal 2025?

Cash from operations of $21.5M minus capital expenditures of $8.6M left free cash flow of $12.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TerrAscend Corp.